Table 3.
Categories | Total (%) P* | DPAM (%) P* | PMCA (%) P* | p | DPAM:PMCA |
---|---|---|---|---|---|
Patient | 36 (100) | 26 (72) | 10 (28) | 0.0032 | 2.6:1 |
Male | 19 (53) | 12 (33) | 7 (19) | 0.0462 | 1.7:1 |
Female | 17 (47) | 14 (39) | 3 (9) | 0.0501 | 4.7:1 |
Soft mucin (SM) | 22 (62) 0.0382 | 18 (50) 0.0329 | 4 (12) 0.050 | 0.0382 | 4.5:1 |
Semi hard mucin (SHM) | 7 (20) | 3 (8) | 4 (12) | 0.5312 | 1:1.3 |
Hard Mucin (HM) | 7 (18) | 5 (14) | 2 (4) | 0.0426 | 2.5:1 |
Ratio:SM:SHM:HM | 3:1:1 | 6:1:1.7 | 2:2:1 | - | - |
Table 3 shows the distribution of 36 patient PMP sample in the two pathologic categories, DPAM and PMCA. Majority of patient samples (72%) are in the DPAM category. Almost twice the number of males has DPAM pathology compared to PMCA, similarly a much higher; almost five times DPAM is found in the females. There is a much higher percentage of soft mucin in DPAM compared to PMCA (ratio being 4.5:1. In the semi hard grade of mucin, the distribution is almost equal in both the pathologic category. Finally, in the hard mucin grade, there is also a higher percentage of DPAM, although much lower as compared for soft mucin. DPAM = disseminated peritoneal adenomucinosis; PMCA = peritoneal mucinous carcinoma; Statistical significance is tested using χ2 test and p values < 0.05 are considered significant. P = comparison of DPAM to PMCA.
distribution of soft mucin in relation to other mucin.